ProKidney (MEX:PROK) Total Stockholders Equity : MXN-17,813.94 Mil (As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is ProKidney Total Stockholders Equity?

ProKidney's Total Stockholders Equity for the quarter that ended in Jun. 2024 was MXN-17,813.94 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. ProKidney's Book Value per Share for the quarter that ended in Jun. 2024 was MXN-141.54. The ratio of a company's debt over equity can be used to measure how leveraged this company is. ProKidney's Debt-to-Equity for the quarter that ended in Jun. 2024 was -0.01.

ProKidney Total Stockholders Equity Historical Data

The historical data trend for ProKidney's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ProKidney Total Stockholders Equity Chart

ProKidney Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

196.22

552.18

-21,379.63

-18,729.32

ProKidney Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Total Stockholders Equity	Get a 7-Day Free Trial										-22,668.59	-19,032.53	-18,729.32	-18,190.52	-17,813.94

ProKidney (MEX:PROK) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

ProKidney's Book Value per Share for the quarter that ended in Jun. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(-17813.937	-	0)	/	125.857
	=	-141.54

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

ProKidney's Debt-to-Equity for the quarter that ended in Jun. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(18.906	+	103.325)	/	-17813.937
	=	-0.01

ProKidney Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of ProKidney's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

ProKidney Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ProKidney Corp (MEX:PROK) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

PROK:USA

Address

2000 Frontis Plaza Boulevard, Suite 250, Winston-Salem, NC, USA, 27103

Website

https://www.prokidney.com

ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease.